Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Onion (Allium cepa) has a long history of use in traditional medicine, but in recent decades, scientific studies have explored its potential benefits for cardiovascular health. The main bioactive compounds in onions—such as flavonoids (especially quercetin), organosulfur compounds, and antioxidants—have been the focus of research regarding their cardioprotective effects.

Several experimental and some clinical studies suggest that onion consumption may help reduce cardiovascular disease (CVD) risk factors. Flavonoids like quercetin have been shown to possess anti-inflammatory, antioxidant, and antihypertensive properties. Some studies indicate that regular intake of onions or their extracts can help reduce blood pressure, lower LDL cholesterol, and inhibit platelet aggregation (clot formation), all of which contribute to cardiovascular protection. The organosulfur compounds in onions may also improve endothelial function and reduce oxidative stress, further supporting vascular health.

However, while animal and in vitro evidence is strong, human clinical trials are fewer and often have small sample sizes or methodological limitations. Meta-analyses and systematic reviews generally conclude that while onions and their constituents are promising, more rigorous, large-scale clinical studies are needed to confirm their effectiveness in preventing or treating cardiovascular disease specifically.

In summary, onions have some scientific support for cardiovascular benefits, primarily based on their bioactive compounds and effects on risk factors, but the overall level of human evidence is moderate, hence the rating of 3 out of 5.

More about onion
More about Cardiovascular Disease

Other ingredients used for Cardiovascular Disease

Other health conditions supported by onion

Products containing onion